Wadih Jordan - Agenus Independent Director
| AJ81 Stock | EUR 7.80 0.00 0.00% |
Director
Mr. Wadih Jordan is an Independent Director of Agenus Inc. Mr. Jordan was most recently the founder and President of NearEast Enterprise, L.L.C. from 2011 to April 2015, a company that marketed pharmaceuticals in Near East markets, including Lebanon, Turkey, Saudi Arabia, Egypt, and the Gulf countries. From 1995 to 2011, Mr. Jordan served as the President of NearEast Pharma LLC, a company that provided pharmaceutical, biotechnology and equipment for pharmaceutical industries to the Near East and Middle East markets. From 1993 to 1995, Mr. Jordan served as a Vice President of Cyanamid International, a researchbased life sciences company, and from 1976 to 1993, Mr. Jordan served as a Managing Director within Cyanamid International. Since December 2003, Mr. Jordan was a trustee of the Board of Directors of the Lebanese American University, located in Beirut, Lebanon, and incorporated under the Board of Regents in New York State. Mr. Jordan received a bachelors degree in agriculture at the American University of Beirut, Lebanon, and a certificate in international business from Columbia University. Mr. Jordan brings to our Board years of expertise in both the biotechnologypharmaceutical and international arenas. since 2003.
| Age | 83 |
| Tenure | 21 years |
| Phone | 781 674 4400 |
| Web | https://www.agenusbio.com |
Agenus Management Efficiency
The company has return on total asset (ROA) of (0.2577) % which means that it has lost $0.2577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (18.903) %, meaning that it generated substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -18.9 | |||
| Return On Asset | -0.26 |
Agenus Inc Leadership Team
Elected by the shareholders, the Agenus' board of directors comprises two types of representatives: Agenus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agenus. The board's role is to monitor Agenus' management team and ensure that shareholders' interests are well served. Agenus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agenus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Stein, Chief Scientific Officer | ||
| James Gorman, Vice President - Strategic Planning and Portfolio Management | ||
| Ozer Baysal, Chief Business Officer | ||
| Regina Grebla, VP Communications | ||
| Shalini Sharp, Director | ||
| John Castle, Head Bioinformatics | ||
| Wadih Jordan, Independent Director | ||
| Christine Klaskin, Principal Financial Officer, Principal Accounting Officer, Vice President - Finance | ||
| Jennifer Buell, Pres Therapeutics | ||
| Don Vidic, Vice President Head of Commercial | ||
| Brian Corvese, Independent Director | ||
| Karen Valentine, Vice President Chief Compliance Officer, General Counsel, Secretary | ||
| Evan Ballantyne, CFO | ||
| Timothy Wright, Lead Independent Director | ||
| Christian Cortis, Chief Strategy Officer and Head of Finance | ||
| Julie DeSander, Chief Officer | ||
| Ulf Wiinberg, Director | ||
| Alexander Duncan, CTO and Head - Research | ||
| Tracy Clemente, Chief Officer | ||
| Allison JeynesEllis, Director | ||
| Garo Armen, Chairman of the Board, CEO | ||
| JeanMarie Cuillerot, Chief Medical Officer | ||
| Andrea Rabney, IR Contact Officer | ||
| Craig Winter, Chief Officer | ||
| Robin JD, Chief Officer | ||
| Shahzad Malik, Independent Director | ||
| Evan Kearns, Vice President General Counsel, Secretary |
Agenus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agenus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -18.9 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (2.39) % | |||
| Operating Margin | (1.99) % | |||
| Current Valuation | 646 M | |||
| Shares Outstanding | 304.81 M | |||
| Shares Owned By Insiders | 8.96 % | |||
| Shares Owned By Institutions | 65.26 % | |||
| Price To Earning | (3.13) X | |||
| Price To Book | 181.30 X |
Pair Trading with Agenus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.Moving against Agenus Stock
| 0.71 | 0QF | Moderna Earnings Call This Week | PairCorr |
| 0.49 | DBPE | Xtrackers LevDAX | PairCorr |
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Agenus Stock analysis
When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |